TeleRay and Radiobotics Enter into a New Partnership to Provide Radiology AI on Fastest Growing Radiology Telehealth Platform

Fremont, CA: The COVID-19 pandemic has resulted in unprecedented – and, in some cases, permanent – changes in healthcare delivery.

In the US, 23 percent of all adults—more than 54 million people—have arthritis and x-rays are sometimes utilized to diagnose these patients. With this new partnership, Radiobotics will provide its FDA-cleared technology, RBknee, for users of the TeleRay platform to automatically analyze knee x-rays for signs of osteoarthritis.

TeleRay CEO Tim Kelley believes that Artificial Intelligence is the ideal complement to TeleRay's existing service delivery and will enable TeleRay to provide even more value to the customers they already serve. "We are always looking for innovative ways to serve our customers' needs and we see an increasing demand for AI in Radiology.